Start an enquiry ↗
Guide · 6 min

Exosomes in skincare: claims, honestly.

Interest in exosomes has run ahead of regulation. For a brand, the commercial question is not only whether an ingredient is interesting, but what the label and the website are permitted to say about it.

Exosome skincare is a young category. Science on the biology is advancing quickly, but approvals, standard definitions and claim guidance have not kept pace. That gap is where brands take risk — and where careful wording earns trust.

Cosmetic or drug: the line that matters

In most markets, a cosmetic is a product intended to cleanse, beautify or alter appearance; a product intended to treat, prevent or change how the body functions is regulated as a drug. The same ingredient can sit on either side depending on what you say about it. Claims about wounds, scarring, hair regrowth, disease or “cell regeneration” are the usual flashpoints.

What the evidence can support

  • Plant-derived vesicles sit comfortably in antioxidant, barrier-care, soothing and brightening concepts, with in-vitro or formulation-level evidence for the specific ingredient
  • Stem-cell-derived vesicles carry more regulatory and donor-source questions; use them only with a clear understanding of each market’s rules
  • Delivery claims — that a vesicle carries an active into skin — need ingredient-specific data, not general exosome literature

Writing defensible copy

  1. Describe the ingredient, not a cure. “Contains plant-derived exosomes characterised by NTA and electron microscopy” is a statement of fact.
  2. Use appearance language. Smoother-looking, more even-looking, visibly soothed.
  3. Cite your own data. A certificate of analysis for the batch is stronger than a link to a review article about a different source.
  4. Keep research and cosmetic grade distinct from clinical grade, and say which one you use.
  5. Avoid borrowed claims. Results from one source, dose or formulation do not transfer to yours.

What to ask your ingredient supplier

A document pack — certificate of analysis, safety data sheet, characterisation summary and stability data — and a plain statement of the intended grade. Without them, even modest claims are hard to defend if a regulator or retailer asks.

Key pointExosomes are a legitimate cosmetic ingredient story when the source is characterised and the claims stay on the appearance side of the line. Check each market’s rules before you publish.

This guide is general information, not legal advice. EXOMIE supplies research and cosmetic-grade ingredients and finished Dermascience products. For ingredient documentation see quality or talk to the team.

Quick answers

Frequently asked

Can a cosmetic claim that exosomes repair or regenerate skin?

Words such as repair, regenerate or treat describe a structure or function of the body and can move a product from cosmetic to drug territory in many markets. Check the rules in each market you sell in, and prefer appearance-based wording supported by evidence.

Are plant exosomes treated differently from human stem-cell exosomes?

Source matters. Human-derived material raises donor, safety and regulatory questions that plant-derived material generally does not. Both still need characterisation and safety testing.

Does the FDA approve exosome products?

The US FDA has said that no exosome product is approved for any use, and has warned against unapproved therapeutic exosome products. Cosmetic use is governed separately from drug use.

Keep reading
Start an enquiry

Questions about your specification?

Tell us the application and the grade you need — we’ll reply with a clear next step.